Influenza and Other Respiratory Viruses


Publication Venue For

  • Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.  14:237-243. 2020
  • Human infection with avian influenza A(H7N2) virus—Virginia, 2002.  12:529-532. 2018
  • Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.  12:267-278. 2018
  • Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.  11:394-398. 2017
  • Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.  11:289-297. 2017
  • CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.  11:2-14. 2017
  • Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins.  8:628-635. 2014
  • Characterizing wild bird contact and seropositivity to highly pathogenic avian influenza A (H5N1) virus in Alaskan residents.  8:516-523. 2014
  • Assessing the impact of public health interventions on the transmission of pandemic H1N1 influenza a virus aboard a Peruvian navy ship.  8:353-359. 2014
  • Severe acute respiratory infections caused by 2009 pandemic influenza A (H1N1) among American Indians-southwestern United States, May 1-July 21, 2009.  7:1361-1369. 2013
  • Improving influenza vaccine virus selection: Report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.  7:52-53. 2013
  • Alexander (Sasha) I. Klimov, PhD, ScD (1943-2013).  7:356-357. 2013
  • Estimating age-specific cumulative incidence for the 2009 influenza pandemic: A meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.  7:872-886. 2013
  • The first cases of 2009 pandemic influenza A (H1N1) virus infection in the United States: A serologic investigation demonstrating early transmission.  6. 2012
  • Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.  3:287-295. 2009
  • Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells..  1:95-104. 2007
  • International Standard Serial Number (issn)

  • 1750-2640
  • Electronic International Standard Serial Number (eissn)

  • 1750-2659